亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。

Antibodies targeting mammalian Sterol Regulatory Element Binding Proteins (SREBP) 1 and 2

技術優勢
§ The developed antibodies have high affinity and specificity for SREBP 1 and 2, relative to commercially available reagents § High utility as a research tool to identify transcriptional targets § Potential robust immunotherapeutic
詳細技術說明
SREBP 1 and 2 are important regulators of fatty acid and cholesterol metabolism, respectively. While these proteins are known to play a significant role in lipid homeostasis, there is still much to be learned about their physiological targets, both related to lipid biosynthesis and other pathways. Recently, UCI researchers identified 426 targets of just SREBP-1. These researchers have prepared antibodies to fragments of SREBP 1 and 2 that have greater affinity and specificity than current commercially available reagents. These novel antibodies are highly desirable tools for studying SREBP in culture and animal models. Furthermore, SREBP antibodies may also be promising immunotherapeutics in metabolic diseases.
*Abstract

Sterol Regulatory Element Binding Proteins (SREBP) are important factors that control lipid homeostasis in mammals. Researchers at UCI have prepared antibodies that have good affinity and specificity for human SREBP1/2 for use as research tools. These antibodies have application in genetic and immunotherapeutic research areas.

*Principal Investigation

Name: Timothy Osborne

Department:

其他

State Of Development

In vivo studies in mouse model


Related Materials

Seo Y-K, Chong HK, Infante AM, Im S-S, Xie X, Osborne TF. Genome-wide analysis of SREBP-1 binding in mouse liver chromatin reveals a preference for promoter proximal binding to a new motif. Proc. Nat. Acad. Sci. 2009, 106, 13765.


Tech ID/UC Case

27241/2015-862-0


Related Cases

2015-862-0

國家/地區
美國

欲了解更多信息,請點擊 這裡
移動設備